Applying interventions designed to reduce and manage the symptoms of substance use disorders.
Treatment
Trauma exposure across the lifespan among individuals engaged in treatment with medication for opioid use disorder: differences by gender, PTSD status, and chronic pain
There is little study of lifetime trauma exposure among individuals engaged in medication treatment for opioid use disorder (MOUD). A multisite study provided the opportunity to examine the prevalence of lifetime trauma and differences by gender, PTSD status, and chronic pain.
Looking Back: A retirement interview with Jeff Lee
Jeff Lee is well known in the field of drug demand reduction and is a founding figure in the creation of ISSUP. For over four decades, Jeff has played a major role in drug prevention and has undertaken and managed projects in more than 80 countries around the world. Jeff finally retired in March from his role as a Senior Consultant for ISSUP. In a quick chat with Jeff, he offers us a glimpse into his successful career, lessons learned, upcoming adventures and hopes for the future.
The 10th Anniversary celebrating of Ahsania Mission Women Drug Treatment Centre
Ahsania Mission Female Drug Treatment Center is celebrating its 10th anniversary a significant achievement for women with substance use disorders The number of female substance users has been increasing alarmingly, but they are lagging...
Join the Power of Collaboration! Sumate al Poder de la Colaboración!
In partnership with ISSUP, we come together to generate global data about the most cross-cutting aspects of the treatment and recovery of women with SUD
Integrating Addiction Medicine with Treatment Courts
This 6-hour, live course provides the education needed for prescribing clinicians to strengthen skills in partnering with treatment court and advocating for patients who are involved in treatment court. The course will include didactive presentations, small group discussions, FAQs, and challenging case studies.
American Academy of Addiction Psychiatry (AAAP) 2024 Annual Meeting and Scientific Symposium
This event provides the latest scientific developments in substance use disorders and co-occurring psychiatric disorders for psychiatrists, primary care physicians, and allied health professionals. The goal of the conference is to recognize emerging issues and trends in addiction psychiatry and be on the forefront of diagnosis and treatment of substance use disorders and co-occurring psychiatric disorders.
CSAM-SMCA 2024 Scientific Conference and Annual Meeting
The CSAM-SMCA 2024 Scientific Conference is Canada’s premier education and networking event for addiction medicine practitioners. This annual event brings together researchers, leaders, educators and clinicians in addiction medicine for three days of learning and networking.
On-the-Spot: Motivational Interviewing
Time: 3PM US Mountain Time
Neonatal Abstinence Syndrome and its Specifics at Temporary Foster Care Institution in the Czech Republic: Study Protocol
INTRODUCTION: Neonatal Abstinence Syndrome (NAS) is a condition unique to a newborn that results from the abrupt cessation of chronic intrauterine drug exposure following birth. Slightly persistent, late onsetting, or slowly fading-out...
Substance Use Disorder in Afghanistan: The Situation and Needs to Address the Issue
INTRODUCTION: More than four decades of war and tragedy have destroyed most of the public infrastructure in Afghanistan. Currently, drug use is a major public health crisis in the country and drug treatment services have extremely limited...